Fundraising Fox
/Companies
Sign in

Radionetics Oncology

Menlo Park, US · Founded 2021 · Delaware corporation · 6 known investors

Find your way into Radionetics Oncology

Sign up to see every warm intro you have to Radionetics Oncology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Radionetics Oncology team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

BEBrett Ewald
Brett EwaldExecutiveBrett Ewald has spent 20 years developing oncology therapeutics across pharma, biotech, and academia, with expertise in radiopharmaceuticals, small molecules, monoclonal antibodies, and immunotherapies. He was a founding employee at a clinical-stage radiopharmaceutical company and served as interim CEO during a financing and strategic planning period.
UG
Umesh GangadharmathExecutiveUmesh Gangadharmath is a radiopharmaceutical scientist with more than 19 years of experience in radiopharmaceutical development and GMP manufacturing. His background includes serving as Assistant Professor and Biomedical Cyclotron Facility Director at UCLA, Senior Scientist in Radiochemistry at Siemens Molecular Imaging, and founding member of Optimal Tracers (a radiopharmaceutical CDMO acquired by Telix Pharmaceuticals), and he currently serves as Chief Technical Officer at Radionetics Oncology.
IMIstvan Molnar
Istvan MolnarExecutiveIstvan Molnar MD is a hematologist-oncologist who trained in internal medicine and hematology-oncology in the United States and previously worked as an Assistant Professor at Wake Forest University before spending two decades in pharmaceutical development at Bayer, Merrimack, Fusion Pharmaceuticals, and Lantheus Medical Imaging, where he held roles ranging from medical affairs to chief medical officer and contributed to regulatory approvals for multiple oncology and imaging drugs.
YZ
Yunfei ZhuExecutive
AKAna Kusnetzow
Ana KusnetzowExecutive
SS
Scott StruthersNamed on SEC filing

Board

AS
Andrew SchwabBoard director
DEDan Estes
Dan EstesBoard directorGeneral Partner at Frazier Life Sciences

Investors · 6

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

5AM VenturesreportedSan Francisco · $100K – $4M

How we know: funding news · Not right? Tell us

DCVC BioreportedPalo Alto

How we know: a partner's Signal profile · funding news · Not right? Tell us

Frazier Healthcare PartnersreportedSeattle · $50M – $400M

How we know: a partner's Signal profile · Not right? Tell us

Westlake Village BioPartnersreportedLos Angeles · $100K – $5M

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$54.2M disclosed across 1 round · 2023

▶$54.2MraisedAug 2023 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Brett EwaldExecutive Officer
  • Andrew SchwabDirector
  • Umesh GangadharmathExecutive Officer
  • Dan EstesExecutive Officer, Director
  • Istvan MolnarExecutive Officer
  • Yunfei ZhuExecutive Officer
  • Ana KusnetzowExecutive Officer
  • Scott StruthersDirector
Offering amount
$68.7M
Amount sold
$54.2M
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Radionetics Oncology's investors?
Radionetics Oncology's investors include DCVC (Data Collective), Frazier Life Sciences, 5AM Ventures, DCVC Bio, Frazier Healthcare Partners, Westlake Village BioPartners.
How much funding has Radionetics Oncology raised?
Radionetics Oncology has disclosed $54.2M raised across 1 round.
Where is Radionetics Oncology headquartered?
Radionetics Oncology is headquartered in Menlo Park, US.